MXPA04005178A - Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem. - Google Patents

Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem.

Info

Publication number
MXPA04005178A
MXPA04005178A MXPA04005178A MXPA04005178A MXPA04005178A MX PA04005178 A MXPA04005178 A MX PA04005178A MX PA04005178 A MXPA04005178 A MX PA04005178A MX PA04005178 A MXPA04005178 A MX PA04005178A MX PA04005178 A MXPA04005178 A MX PA04005178A
Authority
MX
Mexico
Prior art keywords
gemifloxacin
salt
bacterial infections
antibacterial agent
treating bacterial
Prior art date
Application number
MXPA04005178A
Other languages
English (en)
Inventor
Kim Mu-Yong
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of MXPA04005178A publication Critical patent/MXPA04005178A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se relaciona a un metodo para tratar infecciones antibacterianas, el metodo que comprende la administracion separada, simultanea o secuencial a un paciente en necesidad del mismo, de una cantidad efectiva de gemifloxacina, o una sal de la misma y un agente antibacteriano de carbapenem.
MXPA04005178A 2001-11-30 2002-11-29 Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem. MXPA04005178A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33513101P 2001-11-30 2001-11-30
PCT/KR2002/002247 WO2003045389A1 (en) 2001-11-30 2002-11-29 A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent

Publications (1)

Publication Number Publication Date
MXPA04005178A true MXPA04005178A (es) 2004-08-11

Family

ID=23310394

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005178A MXPA04005178A (es) 2001-11-30 2002-11-29 Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem.

Country Status (13)

Country Link
US (1) US20050020567A1 (es)
EP (1) EP1458390B1 (es)
AT (1) ATE404197T1 (es)
AU (1) AU2002360216A1 (es)
CA (1) CA2468033C (es)
CY (1) CY1108472T1 (es)
DE (1) DE60228324D1 (es)
DK (1) DK1458390T3 (es)
ES (1) ES2312654T3 (es)
MX (1) MXPA04005178A (es)
NO (1) NO331599B1 (es)
PT (1) PT1458390E (es)
WO (1) WO2003045389A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090018111A1 (en) * 2004-10-08 2009-01-15 Makoto Sunagawa Novel Antimicrobial Medicament
US9292565B2 (en) * 2010-06-30 2016-03-22 International Business Machines Corporation Template-based recognition of food product information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080757A (en) * 1996-06-06 2000-06-27 Pfizer Inc Antibiotic quinolones and derivatives
ATE419880T1 (de) * 2000-06-09 2009-01-15 Baylor College Medicine Kombination von antimikrobiellen wirkstoffen und bakterieller interferenz zum überziehen medizinischer vorrichtungen

Also Published As

Publication number Publication date
DK1458390T3 (da) 2008-12-15
ES2312654T3 (es) 2009-03-01
EP1458390A1 (en) 2004-09-22
CY1108472T1 (el) 2014-04-09
PT1458390E (pt) 2008-10-02
DE60228324D1 (de) 2008-09-25
NO20042660L (no) 2004-06-24
NO331599B1 (no) 2012-02-06
EP1458390B1 (en) 2008-08-13
CA2468033A1 (en) 2003-06-05
CA2468033C (en) 2008-02-12
US20050020567A1 (en) 2005-01-27
WO2003045389A1 (en) 2003-06-05
EP1458390A4 (en) 2007-07-04
AU2002360216A1 (en) 2003-06-10
ATE404197T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
MXPA02001254A (es) Formulacion de moxifloxacino con sal-comun.
PT759774E (pt) Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
TW200507841A (en) Antibacterial agents
MY138285A (en) Fab i inhibitors
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
AU2003291227A8 (en) Antibacterial agents
WO2005046579A3 (en) Defined dose therapeutic phage
AU2003303956A8 (en) Antibacterial agents
YU102503A (sh) Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
HUE041133T2 (hu) Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
IL162689A0 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
WO2005118613A3 (de) Antibakterielle amid-makrozyklen
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
AU7594301A (en) Derivatives of laspartomycin and preparation and use thereof
PT1223935E (pt) Utilização de compostos de gemifloxacina contra bactérias
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
WO2003061704A3 (en) Combination therapy for the treatment of bacterial infections
MXPA04005178A (es) Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y un agente antibacteriano de carbapenem.
WO2005053613A3 (en) Combinations for the treatment of fungal infections
AUPR916101A0 (en) Method of treating halitosis
AU2003267962A8 (en) Antibacterial compounds and methods for treating gram positive bacterial infections
AU2003209241A1 (en) Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections

Legal Events

Date Code Title Description
FG Grant or registration